Jolly Good

Jolly Good is a medical technology company that develops high-precision VR solutions and AI-based medical and welfare services that analyze user behavior in the VR space. Using these technologies, the company aims to accelerate human growth and social rehabilitation in medical education, support people with disabilities, treatment of mental illness, as well as develop services to support the evolution of medical care. Jolly Good has a DTx division that has partnered with Teijin Pharma to develop VR digital therapeutics for Major Depressive Disorder (MDD). The DTx division will expand their pipeline to other psychiatric diseases and lifestyle diseases. Also, Jolly Good, together with Tokyo's Nippon Medical School, has developed a cloud-based clinical education platform that uses VR.